Pre-order Enquiry
Request Free Sample
Global and United States Sodium Hyaluronate Eye Drops Market Insights, Forecast to 2027
SKU ID : QYR-18669407 | Publishing Date : 30-Jun-2021 | No. of pages : 154
Request Sample
Request Customization
Check Discounts
Sodium hyaluronate eye drops are also known as 'artificial tears'. They are used to relieve eye dryness and soreness.
Global Sodium Hyaluronate Eye Drops key players include URSAPHARM, Santen, Bayer Inc., Bausch & Lomb, Johnson & Johnson, etc. Global top five manufacturers hold a share about 40%.
Asia-Pacific is the largest market, with a share over 45%, followed by North America and Europe, both have a share over 35 percent.
In terms of product, 0.10% is the largest segment, with a share about 40%. And in terms of application, the largest application is Dry Eye, followed by Rewetting.
Market Analysis and Insights: Global and United States Sodium Hyaluronate Eye Drops Market
This report focuses on global and United States Sodium Hyaluronate Eye Drops market.
In 2020, the global Sodium Hyaluronate Eye Drops market size was US$ 292 million and it is expected to reach US$ 440.8 million by the end of 2027, with a CAGR of 6.1% during 2021-2027. In United States the Sodium Hyaluronate Eye Drops market size is expected to grow from US$ XX million in 2020 to US$ XX million by 2027, at a CAGR of XX% during the forecast period.
Global Sodium Hyaluronate Eye Drops Scope and Market Size
Sodium Hyaluronate Eye Drops market is segmented by region (country), players, by Type, and by Application. Players, stakeholders, and other participants in the global Sodium Hyaluronate Eye Drops market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type and by Application in terms of revenue and forecast for the period 2016-2027.
For United States market, this report focuses on the Sodium Hyaluronate Eye Drops market size by players, by Type, and by Application, for the period 2016-2027. The key players include the global and local players which play important roles in United States.
Segment by Type
0.001
0.0015
0.003
Others
Segment by Application
Dry Eye
Rewetting
Others
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
By Company
URSAPHARM Arzneimittel GmbH
Santen
Bayer Inc.
Bausch & Lomb
Johnson & Johnson
The United Laboratories
Alcon
Novax Pharma
Rohto
Thea Pharmaceuticals
Scope Ophthalmics Ltd
Prestige Consumer Healthcare
Medicom Healthcare Ltd
Altacor
Optrex
Global Sodium Hyaluronate Eye Drops key players include URSAPHARM, Santen, Bayer Inc., Bausch & Lomb, Johnson & Johnson, etc. Global top five manufacturers hold a share about 40%.
Asia-Pacific is the largest market, with a share over 45%, followed by North America and Europe, both have a share over 35 percent.
In terms of product, 0.10% is the largest segment, with a share about 40%. And in terms of application, the largest application is Dry Eye, followed by Rewetting.
Market Analysis and Insights: Global and United States Sodium Hyaluronate Eye Drops Market
This report focuses on global and United States Sodium Hyaluronate Eye Drops market.
In 2020, the global Sodium Hyaluronate Eye Drops market size was US$ 292 million and it is expected to reach US$ 440.8 million by the end of 2027, with a CAGR of 6.1% during 2021-2027. In United States the Sodium Hyaluronate Eye Drops market size is expected to grow from US$ XX million in 2020 to US$ XX million by 2027, at a CAGR of XX% during the forecast period.
Global Sodium Hyaluronate Eye Drops Scope and Market Size
Sodium Hyaluronate Eye Drops market is segmented by region (country), players, by Type, and by Application. Players, stakeholders, and other participants in the global Sodium Hyaluronate Eye Drops market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type and by Application in terms of revenue and forecast for the period 2016-2027.
For United States market, this report focuses on the Sodium Hyaluronate Eye Drops market size by players, by Type, and by Application, for the period 2016-2027. The key players include the global and local players which play important roles in United States.
Segment by Type
0.001
0.0015
0.003
Others
Segment by Application
Dry Eye
Rewetting
Others
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
By Company
URSAPHARM Arzneimittel GmbH
Santen
Bayer Inc.
Bausch & Lomb
Johnson & Johnson
The United Laboratories
Alcon
Novax Pharma
Rohto
Thea Pharmaceuticals
Scope Ophthalmics Ltd
Prestige Consumer Healthcare
Medicom Healthcare Ltd
Altacor
Optrex
Frequently Asked Questions
This market study covers the global and regional market with an in-depth analysis of the overall growth prospects in the market. Furthermore, it sheds light on the comprehensive competitive landscape of the global market. The report further offers a dashboard overview of leading companies encompassing their successful marketing strategies, market contribution, recent developments in both historic and present contexts.
- By product type
- By End User/Applications
- By Technology
- By Region
The report provides a detailed evaluation of the market by highlighting information on different aspects which include drivers, restraints, opportunities, and threats. This information can help stakeholders to make appropriate decisions before investing.
